Gilder Gagnon Howe & CO LLC Adagio Therapeutics, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

  • $7.87 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
N/A
-1,231,140 Reduced 98.56%
17,971 $59,000
Q1 2024

May 15, 2024
BUY
N/A
1,249,111 New
1,249,111 $4.13 Million
Q4 2021

Feb 14, 2022
SELL
$6.35 - $47.04 $634,282 - $4.7 Million
-99,887 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$20.88 - $56.08 $2.09 Million - $5.6 Million
99,887 New
99,887 $4.22 Million

Others Institutions Holding ADGI

# of Institutions
78
Shares Held
63.9M
Call Options Held
2.3K
Put Options Held
2.1K
View Full List

About Adagio Therapeutics, Inc.

ADGI Quotes by TradingView
  • Ticker ADGI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,831,000
  • Market Cap $505M
  • Description
  • Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...
More about ADGI
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email